longbridgelongbridge
  • Products
  • Fees
  • Download
  • Promotions
    Welcome RewardsReferral ProgramUS Pre-Market Options Trading
  • For Institutions
    Corporate ServicesDevelopers
  • Help
  • About
    About LongbridgeLicense & RegulatoryMedia CoverageJoin Us
longbridge
  • Home
  • Discover
    Discover
    Global MarketsStock ScreenerFinancial Calendar
  • News & Info
    News & Info
    NewsInsightsLiveAcademy
  • Watchlist
  • Trade
  • Notification
  • LongbridgeAI
Home
Discover
News & Info
Watchlist
Trade
LongbridgeAI
Quote ListQuote List

PepGen(PEPG.US)

Last Updated 19:00:00 ET
longbridge loading
News
Financials
Overview

PepGen Files $400 Million Mixed Shelf

fidelity·Yesterday at 00:23
US
PEPG
+1.81%
US
PBE
+0.89%
US
FBT
+1.23%
fidelity·Yesterday at 00:23
US
PEPG
+1.81%
US
PBE
+0.89%
US
FBT
+1.23%

PepGen Inc. Stock 12‑Month Price Target Cut to $10, Implies 495% Upside

TradingView·05/14/2026 00:20
US
PEPG
+1.81%
US
IBB
+1.80%
US
LABU
+10.25%
TradingView·05/14/2026 00:20
US
PEPG
+1.81%
US
IBB
+1.80%
US
LABU
+10.25%

Wedbush Keeps Their Buy Rating on PepGen Inc. (PEPG)

Tip Ranks·05/13/2026 20:37
US
PEPG
+1.81%
US
ARKG
+3.66%
US
IBB
+1.80%
Tip Ranks·05/13/2026 20:37
US
PEPG
+1.81%
US
ARKG
+3.66%
US
IBB
+1.80%

PepGen | 8-K: FY2026 Q1 Revenue: USD 0

Earnings Watch·05/13/2026 04:20
US
PEPG
+1.81%
Earnings Watch·05/13/2026 04:20
US
PEPG
+1.81%

PepGen, Inc. (NASDAQ:PEPG) Given Average Recommendation of "Moderate Buy" by Brokerages

Market Beat·04/13/2026 16:34
US
PEPG
+1.81%
US
SBIO
+2.76%
US
BBH
+0.22%
Market Beat·04/13/2026 16:34
US
PEPG
+1.81%
US
SBIO
+2.76%
US
BBH
+0.22%

Top 3 Health Care Stocks Which Could Blast Off This Quarter

benzinga_article·04/08/2026 18:40
US
IXJ
+0.08%
US
SBIO
+2.76%
US
VRDN
+5.76%
benzinga_article·04/08/2026 18:40
US
IXJ
+0.08%
US
SBIO
+2.76%
US
VRDN
+5.76%

21:44 ETINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG

prnewswire·04/03/2026 09:45
US
LABU
+10.25%
US
XBI
+3.38%
US
VHT
-0.02%
prnewswire·04/03/2026 09:45
US
LABU
+10.25%
US
XBI
+3.38%
US
VHT
-0.02%
© 2026 Longbridge|Disclaimer

Event Tracking

May13
PepGen released FY2026 Q1 earnings on May 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.26 (forecast USD -0.312)
03:00
Mar5
PepGen released FY2025 Q4 earnings on March 4, 2026 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.2666 (forecast USD -0.3742)
04:00
PepGen released FY2025 Annual Earnings on March 4, 2026 (EST), with actual revenue of USD 0 (forecast USD 0) and actual EPS of USD -2.1234 (forecast USD -2.1628)
04:00
Nov13
PepGen released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.5245 (forecast USD -0.565)
04:00
PepGen released FY2025 9 Months Earnings on November 12, 2025 (EST) with actual revenue of USD 0 and EPS of USD -2.1538
04:00
Oct2
PepGen to showcase positive clinical data for neuromuscular therapies
11:01

Schedules & Filings

Schedules
Filings
May12
Earning Release(EST)

FY2026 Q1 Earning Release (USD) Net Income -17.76 M, EPS -0.26

Mar4
Earning Release(EST)

FY2025 Q4 Earning Release (USD) Net Income -18.34 M, EPS -0.2666

Nov12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -18.03 M, EPS -0.5245

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
OPTH
6.000
+2,451.02%
+5.765
HCWB
2.500
+135.85%
+1.450
FSHPR
0.1666
+105.43%
+0.086
MWC
8.480
+79.66%
+3.741
GCL
0.7678
+77.85%
+0.336
SLXN
0.4703
+74.83%
+0.192
PHGE
0.5684
+51.98%
+0.193
MTVA
2.690
+43.09%
+0.811
EMISR
0.1400
+39.86%
+0.040
HSPTR
0.3100
+39.01%
+0.087
View More